Oruka Therapeutics, Inc.

Historical 13F Holders

Symbol
ORKA
CUSIP
687604108
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 687604108 since 12/18/2024, largest first.

Filer % of Class Filed
Fairmount Funds Management LLC 13D/A
19.5% 7/1/2026
Event 7/1/2026
Venrock Healthcare Capital Partners III, L.P. 13G/A
7.4% 8/14/2026
Event 6/30/2026
T. Rowe Price Investment Management, Inc. 13G 6.6% 11/16/2026
Event 9/30/2026
BlackRock, Inc. 13G 6.6% 1/21/2026
Event 12/31/2025
Capital World Investors 13G 5.6% 8/12/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
RTW Investments, LP 13G/A
4.7% 11/16/2026
Event 9/30/2026
Deep Track Capital, LP 13G/A
4.5% 2/13/2026
Event 12/31/2025
Viking Global Investors LP 13G/A
2.5% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 262 76.7 M $6.43B
2026 Q2 258 74.1 M $7.05B
2026 Q1 186 52.9 M $2.61B
2025 Q4 144 52.9 M $1.55B
2025 Q3 108 45.6 M $876M
2025 Q2 83 34.4 M $386M
2025 Q1 73 31.8 M $326M
2024 Q4 68 31.0 M $607M
2024 Q3 45 24.6 M $604M